Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03978767 · ClinicalTrials.gov registry record · Phase 2
Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial
A Phase 2 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 287
- Enrollment target
NCT03978767 is a Phase 2 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 287 participants.
The verdict
NCT03978767, a Phase 2 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 287 participants
- Enrollment target
Study Summary
A randomized non-inferiority trial of women with preeclampsia with severe features to determine if the addition of nonsteroidal anti-inflammatory drugs is inferior or non-inferior to standard analgesic bundles in their impact on postpartum hypertension.
Interventions
- DRUG Ibuprofen 600 mg
- DRUG Acetaminophen
- DRUG Ketorolac
- DRUG Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2019-06-10 |
| Est. Completion | 2026-06-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03978767
The ClinicalTrials.gov registry entry for NCT03978767 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 287 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ibuprofen 600 mg is the first listed.
NCT03978767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03978767 about?
NCT03978767 is a clinical study titled "Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial". A randomized non-inferiority trial of women with preeclampsia with severe features to determine if the addition of nonsteroidal anti-inflammatory drugs is inferior or non-inferior to standard analgesic bundles in their impact on postpartum hypertension.
What is the current status of trial NCT03978767?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 287 participants. The study started on 2019-06-10. Estimated completion is 2026-06-15.
What interventions are being tested in trial NCT03978767?
The interventions under investigation include: Ibuprofen 600 mg (DRUG), Acetaminophen (DRUG), Ketorolac (DRUG), Oxycodone (DRUG).
Who is sponsoring clinical trial NCT03978767?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.